Selskabets formål er direkte og indirekte at drive fabrikations- og handelsvirksomhed fortrinsvis med produkter indenfor sundhedssektoren, og yde service og rådgivning i tilknytning hertil, samt at drive forsknings-, udviklings- og investeringsvirksomhed og anden virksomhed, der efter bestyrelsens skøn har tilsvarende tilknytning.
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2025 | 27.9 mia. | 3.6 mia. | 48.4 mia. | 16.1 mia. | 16773 | |
CVR: 69749917
Secondary names: COLOPLAST INTERNATIONAL A/S, SCANTAPE A/S, DANSK COLOPLAST A/S
Compared to 296 companies in Fremstilling af medicinske og dentale instrumenter samt udstyr hertil
Comparison is based on industry median values
Companies in the same industry and area
CVR 44316897
CVR 25060458
CVR 40787941
CVR 45175855
CVR 44914492
Gavin Alexander Wood joined as ADM. DIR.
Lars Søren Rasmussen left as ADM. DIR.
Niels Bjørn Christiansen joined the board
Lars Søren Rasmussen left the board
Coloplast A/S demonstrates a strong financial position with significant revenue and profitability, reporting 27.87 billion DKK in revenue and 3.64 billion DKK in profit for 2025. Although profit decreased from 5.05 billion DKK in 2024, the company's equity remains robust at 16.12 billion DKK, indicating a solid foundation for future growth. The revenue trend appears stable, reflecting the company’s established position within the medical and dental instrument manufacturing industry. However, the decline in profit margins may warrant attention as it could signal potential challenges ahead.
AI-generated summary
companydata.dk